COVID-19 and Rheumatoid Arthritis share myeloid pathogenic and resolving pathways (2020)
Attributed to:
Dissecting innate immune determinants of severity and resolution in a longitudinal study of COVID-19
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2020.07.26.221572
Publication URI: http://dx.doi.org/10.1101/2020.07.26.221572
Type: Preprint